These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3158982)

  • 1. [Non-alcoholic hepatic steatosis].
    Boustière C; Gauthier A
    Presse Med; 1985 May; 14(20):1147-50. PubMed ID: 3158982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of intrahepatic triglyceride accumulation.
    Ress C; Kaser S
    World J Gastroenterol; 2016 Jan; 22(4):1664-73. PubMed ID: 26819531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and interpretation of steatosis and steatohepatitis.
    Burt AD; Mutton A; Day CP
    Semin Diagn Pathol; 1998 Nov; 15(4):246-58. PubMed ID: 9845426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver steatosis: recent advances.
    Thaler H
    Recenti Prog Med; 1990 Jun; 81(6):420-5. PubMed ID: 2251448
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute hepatic steatosis. Description of a clinical case of sodium valproate-induced acute hepatic steatosis].
    Coraggio F; Angiulli B; Carbone M; Catalano A; Costa MR; Gargiulo L; Gentile B; Masetto O; Pomponio N; Scarpato P
    Clin Ter; 1988 Mar; 124(6):451-63. PubMed ID: 2974353
    [No Abstract]   [Full Text] [Related]  

  • 6. Microvesicular steatosis of the liver.
    Hautekeete ML; Degott C; Benhamou JP
    Acta Clin Belg; 1990; 45(5):311-26. PubMed ID: 2177300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty liver.
    Thaler H
    Tokai J Exp Clin Med; 1980 Apr; 5(2):233-42. PubMed ID: 7414634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis.
    Wu JW; Wang SP; Alvarez F; Casavant S; Gauthier N; Abed L; Soni KG; Yang G; Mitchell GA
    Hepatology; 2011 Jul; 54(1):122-32. PubMed ID: 21465509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
    Larter CZ; Yeh MM; Van Rooyen DM; Teoh NC; Brooling J; Hou JY; Williams J; Clyne M; Nolan CJ; Farrell GC
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1658-68. PubMed ID: 19788606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasonically undetectable fatty liver in acute fatty liver of pregnancy and Reye's syndrome.
    Shimizu M; Okumura M; Yuh K; Oita J; Shimizu H
    J Clin Ultrasound; 1985; 13(9):679-82. PubMed ID: 3935687
    [No Abstract]   [Full Text] [Related]  

  • 11. Do NSAIDs contribute to acute fatty liver of pregnancy?
    Baldwin GS
    Med Hypotheses; 2000 May; 54(5):846-9. PubMed ID: 10859699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Abdominal obesity: metabolic complications and consequences for the liver].
    Oldenburg B; Pijl H
    Ned Tijdschr Geneeskd; 2001 Jul; 145(27):1290-4. PubMed ID: 11475019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined metadoxine and garlic oil treatment efficaciously abrogates alcoholic steatosis and CYP2E1 induction in rat liver with restoration of AMPK activity.
    Ki SH; Choi JH; Kim CW; Kim SG
    Chem Biol Interact; 2007 Aug; 169(2):80-90. PubMed ID: 17606256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of apolipoprotein A5 in non-alcoholic fatty liver disease.
    Ress C; Moschen AR; Sausgruber N; Tschoner A; Graziadei I; Weiss H; Schgoer W; Ebenbichler CF; Konrad RJ; Patsch JR; Tilg H; Kaser S
    Gut; 2011 Jul; 60(7):985-91. PubMed ID: 21339203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
    Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compound K modulates fatty acid-induced lipid droplet formation and expression of proteins involved in lipid metabolism in hepatocytes.
    Kim MS; Lee KT; Iseli TJ; Hoy AJ; George J; Grewal T; Roufogalis BD
    Liver Int; 2013 Nov; 33(10):1583-93. PubMed ID: 23998390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive diagnosis of steatosis and fibrosis.
    Castera L
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):674-9. PubMed ID: 19195629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease: diagnosis and management.
    Wilkins T; Tadkod A; Hepburn I; Schade RR
    Am Fam Physician; 2013 Jul; 88(1):35-42. PubMed ID: 23939604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Common occurrence of non-alcoholic fatty liver disease and cholecystolithiasis].
    Fraenkel E; Takács R; Hamvas J; Lengyel G; Fehér J
    Orv Hetil; 2007 Apr; 148(17):793-8. PubMed ID: 17452309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.